Rapid early action for coronary treatment: Rationale, design, and baseline characteristics

Academic Emergency Medicine

Volumn 5, Issue 7, 1998, Pages 726-738

  Simons Morton, Denise G ^a   Goff, David C ^b   Osganian, Stavroula ^c   Goldberg, Robert J ^d   Raczynski, James M ^e   Finnegan, John R ^f   Zapka, Jane ^d   Eisenberg, Mickey S ^g   Proschan, Michael A ^a   Feldman, Henry A ^c   Hedges, Jerris R ^h   Luepker, Russell V ^f  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g Public Health Seattle King County   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acute myocardial infarction; Community intervention

Indexed keywords

ARTICLE; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; EDUCATION PROGRAM; EMERGENCY TREATMENT; FIRST AID; PRIORITY JOURNAL; THORAX PAIN; TREATMENT OUTCOME;

EID: 7344240954     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1998.tb02492.x     Document Type: Article

References (59)

1. Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol. 1990; 16:223-31.
2. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993; 270:1211-6.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for ftbrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994; 343:311-22.
4. Holmes DR Jr., Califf RM, Topol EJ. Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries. J Am Coll Cardiol. 1995; 25:10S-17S.
5. Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol. 1996; 27: 1646-55.
6. Cannon CP, Braunwald E, McCabe CH, Antman EM, for the TIMI Investigators. The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. J Intervent Cardiol. 1995; 8: 117-35.
7. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993; 328:673-9.
8. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993; 328:680-4.
9. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993; 328:685-91.
10. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD, for the Myocardial Infarction Triage and Intervention Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 1996; 335:1253-60.
11. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 1993; 342:891-4.
12. Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol. 1994; 23:1023-30.
13. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994; 90:2103-14.
14. Goff DC Jr., Nichaman MZ, Ramsey DJ, Meyer PS, Labarthe DR. A population-based assessment of the use and effectiveness of thrombolytic therapy. The Corpus Christi Heart Project. Ann Epidemiol. 1995; 5:171-8.
15. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med. 1996; 334:884-90.
16. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction. A fourstate pilot study from the Cooperative Cardiovascular Project. JAMA. 1995; 273:1509-14.
17. Alonzo AA. The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease. Soc Sci Med. 1986; 22:1297-311.
18. Dracup K, Moser DK. Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction. Heart Lung. 1991; 20:570-5.
19. Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med. 1995; 40:379-92.
20. Goldberg RJ, Gurwitz J, Yarzebski J, et al. Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol 1992; 70:421-5.
21. Clark LT, Bellam SV, Shah AH, Feldman JG. Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention. J Natl Med Assoc. 1992; 84:931-7.
22. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Ann Emerg Med. 1994; 23:311-29.
23. Proceedings of the National Heart, Lung and Blood Institute Symposium on Rapid Identification and Treatment of Actue Myocardial Infarction. Washington, DC: GPO, 1991, pp 1 -157.
24. Ho MT. Delays in the treatment of acute myocardial infarction: an overview. Heart Lung. 1991; 20:566-9.
25. Rowley JM, Hill JD, Hampton JR, Mitchell JR. Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J. 1982; 284:1741-6.
26. Meischke H, Dulberg EM, Schaeffer SS, Henwood DK, Larsen MP, Eisenberg MS. "Call fast, call 911": A direct mail campaign to reduce pre-hospital delay and increase use of 911 in acute myocardial infarction. Am J Public Health. 1997; 87:1705-9.
27. Meischke H, Eisenberg MS, Schaeffer SM, Larsen MP, Henwood DK. Impact of direct mail intervention on knowledge, attitudes, and behavioral intentions regarding use of emergency medical services for symptoms of acute myocardial infarction. Eval Health Prof. 1994; 17:402-17.
28. Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can J Public Health. 1984; 75:414-8.
29. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med. 1989; 18: 727-31.
30. Rustige JM, Burczyk U, Schiele R, Werner A, Senges J. Media campaign on delay times in suspected myocardial infarction: The Ludwigshafen Community Project [abstract]. Eur Heart J. 1990; 11:171.
31. Herlitz J, Hartford M, Blohm M, et al. Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol. 1989; 64:90-3.
32. Herlitz J, Hartford M, Karlson BV, et al. Effect of a media campaign to reduce delay times for acute myocardial infarction on the burden of chest pain patients in the emergency department. Cardiology. 1991; 79:127-34.
33. Blohm M, Herlitz J, Schroder U, et al. Reaction to a media campaign focusing on delay in acute myocardial infarction. Heart Lung. 1991; 20:661-6.
34. Moses HW, Engelking N, Taylor GJ, et al. Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. Am J Cardiol. 1991; 68:249-51.
35. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hosital time delays in suspected acute myocardial infarction [abstract]. Circulation. 1993; 88:1-13.
36. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart. 1996; 76:150-5.
37. Bett N, Aroney G, Thompson P. Impact of a national educational campaign to reduce patient delay in possible heart attack. Aust N Z J Med. 1993; 23:157-61.
38. Eppler E, Eisenberg MS, Schaeffer S, Meischke H, Larson MP. 911 and emergency department use for chest pain: results of a media campaign Ann Emerg Med. 1994; 24:202-8.
39. Feldman HA, Proschan MA, Murray DM, et al. Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multi-site community trial with continual data collection. Control Clin Trials, in press.
40. ICD-9-CM. International Classification of Diseases. Clinical Modification. 4th ed. Los Angeles, CA: Practice Management Information Corporation, 1995.
41. Raczynski JM, Taylor H, Cutter G, Hardin M, Rappaport N, Oberman A. Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart disease. Am J Public Health. 1994; 84:951-6.
42. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, 1986, pp 1-617.
43. Perry CL, Baranowski T, Parcel GS. How individuals, environments, and health behavior interact: social learning theory. In: Glanz K, Lewis FM, Rimer BK (eds). Health Behavior and Health Education. Theory Research and Practice. San Francisco: Jossey-Bass, 1991, pp 161-86.
44. Leventhal H. Emotional and behavioural processes. In: Johnston M, Wallace L (eds). Stress and Medical Procedures. Oxford: Oxford University Press, 1990, pp 25-57.
45. Rogers EM. Diffusion of Innovations. 3rd ed. New York: The Free Press, 1983, pp 1-453.
46. Novelli WD. Developing marketing programs. In: Frederiksen LW, Solomon LJ, Brehony KA (eds). Marketing Health Behavior: Principles, Techniques and Applications. New York: Plenum Press, 1984, pp 59-89.
47. Lefebvre RC, Rochlin L. Social marketing. In: Glanz K, Lewis FM, Rimer BK (eds). Health Behavior and Health Education: Theory, Research and Practice. San Francisco: Jossey-Bass, 1997, pp 384-402.
48. Bracht NF. Health Promotion at the Community Level. Newbury Park, CA: Sage Publications, 1990, pp 1-320.
49. Raczynski J, Finnegan J, Meischke H, et al. REACT intervention design: a theoretically-based intervention to reduce treatment-seeking delay for acute MI symptoms. Can J Cardiol. 1997; 13:298B.
50. Simons-Morton DG, Simons-Morton BG, Parcel GS, Bunker JF. Influencing personal and environmental conditions for community health: a multilevel intervention model. Fam Community Health. 1988; 11:25-35.
51. Green LW, Kreuter MW. Health Promotion Planning: An Educational and Environmental Approach. 2nd ed. London: Mayfield Publishing, 1991, pp 1-506.
52. Simpson JM, Klar N, Donnor A. Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. Am J Public Health. 1995; 85:1378-83.
53. Elder JP, Wildey M, de Moor C, et al. The long-term prevention of tobacco use among junior high school students: classroom and telephone interventions. Am J Public Health. 1993; 83:1239-44.
54. Farquhar JW, Fortmann SP, Flora JA, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990; 264:359-65.
55. Luepker RV, Murray DM, Jacobs DR, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health. 1994; 84:1383-93.
56. Luepker RV, Perry CL, McKinlay SM, et al. Outcomes of a field trial to improve children's dietary patterns and physical activity. The Child and Adolescent Trial for Cardiovascular Health. CATCH Collaborative Group. JAMA. 1996; 275:768-76.
57. Green SB, Corle DK, Gail MH, et al. Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol. 1995; 142:587-93.
58. The COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health. 1995; 85: 193-200.
59. The COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): I. Cohort results from a four-year community intervention. Am J Public Health. 1995; 85:183-92.